Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid

Clinical trial NCT00007020 · COMPLETED

Trial details

NCT number: NCT00007020
Sponsor: Mirum Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infantile Refsum's Disease Zellweger Syndrome Adrenoleukodystrophy Peroxisomal Disorders Cholestasis

Start date: 1992-01-01
Primary completion: 2009-12-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.